FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs

被引：4

作者：

Simantirakis, Emmanouil ^{[1
]}

Tsironis, Ioannis ^{[1
]}

Vassilopoulos, George ^{[1
,2
]}

机构：

[1] Acad Athens, Biomed Res Fdn, Gene Therapy Lab, Div Genet & Gene Therapy,Basic Res 2, Athens 11527, Greece

[2] Univ Thessaly, Div Hematol, Med Sch, Larisa 41500, Greece

来源：

VIRUSES-BASEL | 2020年 / 12卷 / 03期

关键词：

foamy virus; gene therapy; HSC; gene marking; FV gene transfer to HSCs; gene therapy alternatives; FOAMY VIRUS VECTOR; HEMATOPOIETIC STEM-CELLS; CHRONIC GRANULOMATOUS-DISEASE; GAMMARETROVIRAL VECTORS; RETROVIRAL VECTOR; HEPARAN-SULFATE; TRANSDUCTION; THERAPY; IMMUNODEFICIENCY; INTEGRATION;

D O I：

10.3390/v12030332

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Hematopoietic Stem Cells (HSCs) are a unique population of cells, capable of reconstituting the blood system of an organism through orchestrated self-renewal and differentiation. They play a pivotal role in stem cell therapies, both autologous and allogeneic. In the field of gene and cell therapy, HSCs, genetically modified or otherwise, are used to alleviate or correct a genetic defect. In this concise review, we discuss the use of SFVpsc_huHSRV.13, formerly known as Prototype Foamy Viral (PFV or FV) vectors, as vehicles for gene delivery in HSCs. We present the properties of the FV vectors that make them ideal for HSC delivery vehicles, we review their record in HSC gene marking studies and their potential as therapeutic vectors for monogenic disorders in preclinical animal models. FVs are a safe and efficient tool for delivering genes in HSCs compared to other retroviral gene delivery systems. Novel technological advancements in their production and purification in closed systems, have allowed their production under cGMP compliant conditions. It may only be a matter of time before they find their way into the clinic.

引用

页数：13

共 50 条

[1] Lentivirus vectors as gene transfer vehicles in cancer gene therapy
Pellinen, R
Hakkarainen, T
Pasanen, T
Tulimäki, K
Ketola, A
Tenhunen, A
Wahlfors, J
[J]. MOLECULAR THERAPY, 2003, 7 (05) : S335 - S335
[2] Canine adenovirus vectors: an alternative for adenovirus mediated gene transfer
Kremer, EJ
Boutin, S
Chillon, M
Danos, O
[J]. JOURNAL OF VIROLOGY, 2000, 74 (01) : 505 - 512
[3] Alternative, gene therapeutic approaches to treatment of tetrahydrobiopterin deficiency by gene transfer: Generation of retroviral vectors
Laufs, S
Leimbacher, W
Kim, S
Blau, N
Thony, B
[J]. CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, 1997, : 737 - 740
[4] Vectors - Shuttle vehicles for gene therapy
Wilson, JM
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 : 31 - 32
[5] Novel Gene Transfer Systems: Intelligent Gene Transfer Vectors for Gene Medicines
Nakajima, Toshihiro
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (15) : 1594 - 1602
[6] Adenoviral vectors for gene transfer
Kovesdi, I
Brough, DE
Bruder, JT
Wickham, TJ
[J]. CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (05) : 583 - 589
[7] Chemically surface modified AAV6 vectors combined with nanoblades are a promising alternative for gene knock-in in HSCs
Gutierrez-Guerrero, A.
Leray, A.
Perian, S.
Alvarez-Dorta, D.
Ayuso, E.
Cosset, F. L.
Deniaud, D.
Mevel, M.
Verhoeyen, E.
[J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A63 - A63
[8] Densovirinae as gene transfer vehicles
Afanasiev, B
Carlson, J
[J]. PARVOVIRUSES: FROM MOLECULAR BIOLOGY TO PATHOLOGY AND THERAPEUTIC USES, 2000, 4 : 33 - 58
[9] Erythroviruses as gene transfer vehicles
Srivastava, A
Kurpad, C
Yoder, MC
[J]. PARVOVIRUSES: FROM MOLECULAR BIOLOGY TO PATHOLOGY AND THERAPEUTIC USES, 2000, 4 : 133 - 148
[10] Gene Transfer to HSCs: Finding the Leukemia in Murine Leukemia Viruses
Cornetta, Kenneth
[J]. MOLECULAR THERAPY, 2019, 27 (06) : 1072 - 1073

← 1 2 3 4 5 →